MediWales Review - Spring 2009 by Teamworks

REVIEW-Arab Health 10

11/1/10

11:11

Page 1

M E D I W A L E S F

M A G A Z I N E B

S P R I N G D

2 0 0 9 H

BioWales 2010

Welsh bioscience goes global

Winning performers 2009 MediWales Innovation Award winners

Arab Health Company Directory

Showcases Ultrasound Technologies Ltd DTR Medical Boots Centre for Innovation

MEDIWALES IS SUPPORTED BY THE WELSH ASSEMBLY GOVERNMENT

REVIEW-Arab Health 10

11/1/10

11:12

Page 2

REVIEW-Arab Health 10

11/1/10

11:12

Page 3

Rewards, Awards and Promotion The Spring Edition of the MediWales Review focuses on three events, each promoting the products and expertise in the bioscience sectors in Wales: BioWales 2010, our own MediWales Innovation Awards and the Arab Health Exhibition. BioWales 17 - 18 March, The Vale Hotel, The Vale of Glamorgan BioWales is one of the UK's largest Bioscience conferences and biopartnering events held outside of London, and has been running for 8 years. Once again it will be held at the Vale Hotel near Cardiff, and speakers will include the Nobel Prize winner, Professor Sir Martin Evans. Last year 381 delegates attended including companies and academics aiming to create new connections and seeking licensing and business developments opportunities. MediWales Annual Innovation Awards Our biggest event yet, with over 160 guests, MediWales members, award winners past and present and VIP guests. These awards have become a landmark event for the Welsh Lifescience sector. The 4th Annual Awards ceremony was held on 1st December, at the Cardiff Hilton, and celebrated the presentation of 6 Industry awards, and 3 new categories for Innovation in the NHS. Arab Health 25 - 28 January 2010 Dubai International Convention and Exhibition Centre, UAE. The Welsh Pavillion: Hall 7 B53. The Arab Health exhibition is the premier healthcare event for the Middle East. This event plays host to healthcare manufacturers, wholesalers and distributors. providing a valuable arena in which to meet with some of the most important decision makers in the Arab world. With rapid year-on-year growth, Arab Health now has over 2,500 exhibitors from 65 countries including over 100 stands from UK companies.

The show will attract over 50,000 visitors over the four-day event. Welsh Companies Several companies will be exhibiting from Wales, including Ultrasound Technologies, Roma Medical Aids, Chromogenex, and DTR Medical. International Business Wales (IBW) is the organiser of the Welsh Pavilion at Arab Health. IBW is the international trade and investment arm of the Welsh Assembly Government. They act as a driving force in establishing alliances between companies in Wales and their counterparts overseas. IBW also actively encourages inward investment from overseas companies looking to Europe and the UK as a preferred international business location.

Contents BioWales

4-7

MediWales Innovation Awards 10-13 Arab Health Special

Welsh Pavilion Directory

18-19

Showcases

20-22

Welsh Medical Technology Wales has a long and distinguished history of industrial innovation and achievement. We have around 330 companies operating in the Welsh bioscience sector, including health technologies, whose combined turnover is approximately ÂŁ1.3bn per year, with the sector employing around 15,000 people. Wales has a strong business base, globally respected academic institutions, and world-renown sporting and cultural venues. MediWales is the industry-owned forum, established to service the life science organisations in Wales. Over the last seven years, MediWales has become the sector representative and central point of contact, influencing Welsh and UK sector development strategies and providing active routes for member companies to access clinical and academic expertise. Part of MediWales's role is to act as a signposting and business support service for its members. It is similarly happy to assist international contacts in sourcing commercial and collaborative research and development partners in Wales.

M E M B E R

7 Schooner Way, Atlantic Wharf, Cardiff CF10 4DZ Telephone: +44 (0)29 2047 3456 Forum Manager: gwyn.tudor@mediwales.com Project Manager: debbie.laubach@mediwales.com Project Coordinator: jo.daniel@mediwales.com (Contact for editorial and advertising) Web:

www.mediwales.com

MediWales Chairman: Mr Greg Baily, Huntleigh

MediWales is a founder member of Medilink UK, the network of regional medical technology organisations that represents the interests of around 3000 organisations across the UK.

The MediWales Review is designed by Teamworks Design Consultants

REVIEW-Arab Health 10

M E D I W A L E S

11/1/10

11:13

R E V I E W

Page 4

S P R I N G

2 0 1 0

B I O W A L E S

BioWales: thriving in adversity BioWales 2010 comes armed with renewed vitality: despite the recession, current statistics show that the Bioscience sector in Wales is thriving. Contributing over ÂŁ1.3bn to the Welsh economy, with over 330 businesses involved, the industry employs more than 15,000 people. This sector has a lot to shout about and BioWales is the perfect flagship to showcase its successes. The first BioWales conference held in 2002 - a small, but ambitious affair - has grown into what is now one of the largest bioscience conference and biopartnering event in the UK. Spanning two days, BioWales plays host to a range of activity: there are presentations from world-renowned speakers, a

brokerage session with one-to-one meetings, workshops on dedicated topics, with a trade-show exhibition running throughout. This multi-faceted conference strives to be 'fit for purpose' and is reformatted year on year to reflect and adapt to the needs of industry.

This year's major change is the introduction of workshops to the programme. Delegate feedback indicated that companies want a stronger interactive element to the conference, allowing them to discuss topics that potentially underpin their success in the market.

REVIEW-Arab Health 10

11/1/10

11:13

Page 5

Companies also stated that gaining access to finance has become increasingly difficult in current economic times. In response to these concerns, the Welsh Assembly has created three workshops dedicated to funding and finance. The first workshop - run by the Assembly's Research and Development Advisor, Lisa Wheatley - is titled 'Funding opportunities from the EU Framework Funding Programme'. This session will advise businesses on what FP7 funding is available, how to access it and how to write successful proposals. The second session, titled 'Finance' will be co-run by Brenig Preest from Excalibur Group and Meurig Watts from the Welsh Assembly Government. This session will discuss funding opportunities in

Wales such as Flexible Support for Business (FS4B) and the Academic for Business (A4B) programmes. Funding is also available through Finance Wales and Excalibur. The final workshop - 'Inward Investment Opportunities' - will give an overview of the sector, highlighting the skills and sector support available to companies. The organisers also responded to delegate feedback by restructuring the brokerage sessions. These have been reconfigured to enable more one-to-one sessions between organisations, and also to ensure that the right people talk to each other. The Brokerage activity is central to the BioWales mix, running throughout the two days. It is also a part of the conference that has

exponentially grown year on year: 2009's brokerage had over 350 meetings, up from 225 the previous year. Coordinating this impressive set up is Dr Sharon Thomas, the Welsh Assembly Government's Healthcare and Life Science Specialist at the Department of Economy and Transport. She described the new 'accept and decline' system for the brokerage event and why it is being implemented 'It all starts with an initial call for interested parties to take part via online registration.' Those seeking brokerage meetings are linked to Bio-partnering registration through the EU Enterprise Europe Network (EEN). The EEN facilitates technology transfer throughout the UK and

REVIEW-Arab Health 10

11/1/10

11:13

Page 6

B I O W A L E S 6

Europe, bringing together those seeking or offering technology opportunities, as well as supporting access to Europeanwide research funding frameworks. Sharon continued 'Each organisation submits a technology profile, which can consist of an offer or request for technology, know-how or expertise. All profiles then get entered into the online catalogue. Approximately two weeks before the conference all registrants are asked to view the catalogue and select other organisations that they'd like to meet with. In the past, once a request had been made for a meeting that would be automatically entered into the meeting schedule, however feedback from last year indicated that at times there was a missmatch between companies something that we are keen to

avoid. This new 'accept or decline' system allows the requested company to either accept or decline the meeting depending on their requirements. This makes sure that every company only has a schedule that is 100% worthwhile to them.' Sharon's dedication to perfecting BioWales's brokerage process has been catalysed due to the deals and collaborations that have occurred since the last conference. 'In just the first six months alone, as a result of the brokerage, licensing deals have increased by 100%' Sharon continues, 'There has also been a significant rise is R&D applications under collaborative grants. The brokerage event is very successful and these results show a genuine need and purpose for it to grow and continue.'

BioWales is fully supported by the Welsh Assembly Government, who contracted MediWales to deliver the 2010 speaker programme. Working with Sharon and her team, MediWales has devised an high profile line up including sessions on the following topics: translational research; stem cells industrialisation for drug development and therapy; point of care diagnostics; cancer genetics; and “futurewatch” - an introduction to what's hot and new in bioscience today. The headline session - stem cell research and regenrative medicine - is currently very high profile across the UK, but especially in Wales. The session also headlines Stephen Minger, head of research and development for cell technologies at GE Healthcare and recently featured on the BBC Horizon programme: ‘Fix Me’ (November 09).

REVIEW-Arab Health 10

11/1/10

11:13

Page 7

Dr Sharon Thomas on BioWales 2010 Tell us a little about the history of BioWales? BioWales started as a small conference in 2002, centred on bioscience research in Wales, to allow academia and industry professionals to network. This initial conference had 170 delegates and was a great success. The next event in 2004 attracted even more delegates, and BioWales has grown year on year. What’s planned for BioWales 2010? BioWales 2010 will be our biggest conference to date. After listening to feedback from last year, we have introduced new workshop sessions over the two days. We have booked full sized stands in a larger exhibition area, as we are anticipating a high number of delegates. We are also offering a technology brokerage service on an accept/decline

basis. Last year the brokerage service proved very popular and generated over 350 meetings. Who is speaking at BioWales 2010? This year’s programme features a mixture of UK and International speakers, including Sir Martin Evans, who specialises in knock-out genes and has inaugurated a new spin out company. He has done stem cell work with key industry figures, including Steve Dennet, Charlie Archer and the dental school at Cardiff University. What does BioWales offer the Welsh Lifescience industry? BioWales is the biggest bioscience conference in Wales. The conference profiles internationally and locally renowned speakers, attracting a wide range of delegates from Wales, the wider healthcare and lifescience communities from the UK and beyond.

This makes it an excellent opportunity for high quality networking and profiles exciting new developments in lifesciences. What can Biowales 2010 offer companies? It gives Welsh bioscientists the chance to promote themselves and their organisations on an international stage. International companies in turn will have exposure to the Welsh organisations, and develop an understanding of what Wales has to offer. It will allow people from outside of Wales the chance to gain access to Welsh academia and NHS professionals, as well as information such as licensing, collaboration opportunities and FP7 funding. IBW are supporting the programme, giving Welsh companies the opportunity to access assistance and advice on international trade.

BioWales 2010

Wales’ largest bioscience conference, exhibition and biopartnering event. 17th and 18th March 2010 The Vale Hotel, Golf & Spa Resort, Hensol near Cardiff, UK* BioWales 2010 sessions will feature: ● Translational Research – what is it? ● Stem Cells – industrialisation for drug development and therapy. ● Point of care diagnostics. ● Cancer Genetics. ● Futurewatch – an introduction to what’s hot and new in bioscience today. Biopartnering Event at BioWales 2010 Run by Enterprise Europe Network Wales and linked to the EU Enterprise Europe Network, the Biopartnering event provides a catalogue of high quality technology profiles and a base allowing one to one meetings to discuss partnering opportunities.

BioWales 2010 introduces the Welsh bioscience sector to an international, commercial, academic and NHS audience. BioWales features : ● Presentations from innovative companies and academia ● Face to face partnering meetings ● Spotlight on bioscience exhibiting companies ● Workshops ● 2 days of networking opportunities Speakers for stem cell session include: • Stephen Minger, GE Healthcare • Nobel Prize winner, Professor Sir Martin Evans • Anthony H Davies, Geron Corporation

To make the most of BioWales 2010 register NOW at – www.biowalesevent.com *Just 2 hours from London, 30 minutes from Cardiff International Airport with ample free parking.

REVIEW-Arab Health 10

11/1/10

11:13

Page 8

Q Chip

, a biopharmaceutical drug delivery company, is developing Q-Sphera™ a range of injectable sustained-release biosimilar and biotherapy products. Q-Sphera products are biocompatible microspheres containing active pharmaceutical ingredient (API), made using Q Chip's patented encapsulation platform the MicroPlant™ device. The key advantages of the Q-Sphera format are: ●

The microspheres are extremely monodispersed with a high encapsulation efficiency of API

●

It is API neutral

●

Fast and inexpensive drug development

●

Low cost manufacturing for biosimilars

Q Chip's lead biosimilar products are Q-Leuprolide (primary indication for prostate cancer) and Q-Octreotide (primary indication for acromegaly). Q-Sphera is also highly enabling for the encapsulation of fragile proteins for bio-therapeutic use.

Oddfellows House, 19 Newport Rd, Cardiff, CF24 0AA, Wales (UK) Tel: +44 (0) 29 2048 0180 Email: info@q-chip.com Web: www.q-chip.com

REVIEW-Arab Health 10

11/1/10

11:14

Page 9

........Accessible Biotechnology and Consultancy Services

Gene Expression Analysis DNA Sequencing Services Illumina Technology Affymetrix Technology Cell Sorting & Flow

Cytometry MesoScale Discovery Protein Production Proteomics & Biacore Histology Services

CONTACT DETAILS: For further information about our ISO accredited services, please contact Dr Anna Hurley (CBS Manager) at CBSadmin@cardiff.ac.uk, or visit us at www.cardiff.ac.uk/medic/CBS.

!"#$%"&'(%&)*#(+"*,$-&.!)+/

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

!!!"56&%"+06"()

!!!"#!$%#&$"$'"()*%$%+,&$-.,

@;%&3"AB"%?C

012&3"456*,&7$4

7*?"% 356%(A*6-5#5#D 75A5$"4 .737/&

I!J8L),#-'38M.,8$0)-#'3#$)$8#(80/14#,#(285),#-'380/1;)$$#1('3$8&#."8"#2" F6'3#.78#((14'.#4)8$#(23)*6$)8$.)/#3)8#($./65)(.$8."'.8,)3#4)/80'.#)(.8'(, -3#(#-'384'36)98-15+#(),8&#."8):-)0.#1('383)4)3$81;8$)/4#-)<

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

E$8'(8):0)/#)(-),85),#-'38,)4#-)85'(6;'-.6/)/8;1/85'(78$0)-#'3#.#)$9 I!J8L),#-'38M.,8"'(,3)$8,)$#2(8N3)$8'(,8=A85'/@#(2$< I!J8L),#-'38"'$8.&18O%P8=3'$$8Q8R-3'$$8ST9TTTU8-3)'(/115$8'(,8'(8):0)/#)(-), 0/1,6-.#1(8'(,8F6'3#.78.)'5<8!")8;'-#3#.78-1(.'#($8$0)-#'3#$.8'$$)5+378'(, 0'-@'2#(285'-"#()/78.18"'(,3)8'8&#,)8/'(2)81;85),#-'38,)4#-)$< O(8',,#.#1(98.18VTT8I!J8L),#-'380/1,6-.$98.")8-150'(78-1(./'-.85'(6;'-.6/)$ 14)/8STT8$.)/#3)85),#-'38,)4#-)$8'(,8-6$.1580'-@$8;1/81.")/85),#-'38,)4#-) 5'(6;'-.6/)/$< !!!"/.01&/2'$-"'+1 W1/851/)8#(;1/5'.#1(81(8XYA>8'(,8#.$81;;)/#(2$ )5'#382%3+456&%"+06"()71/84#$#.C8!!!"56&%"+06"()

REVIEW-Arab Health 10

M E D I W A L E S

11/1/10

10:55

R E V I E W

Page 10

S P R I N G

A W A R D S

2 0 1 0

MediWales Awards 2009 The Annual MediWales Innovation Awards, our chance to celebrate the successes and advances of Welsh companies in the Bioscience sector. The categories recognising industry success are Innovation; Export Achievement; Start-up; Outstanding Growth; Partnership with the NHS; and the Judgesâ&#x20AC;&#x2122; Award. For the first time, the 2009 Awards also included three extra categories for NHS personnel, in order to commend the achievements within the Welsh NHS.

Innovation Award WINNER: Firefly Medical Ltd www.fireflymedical.co.uk PRIZE SPONSOR: Gambit Corporate Finance www.gambitcf.com

Start Up Award WINNER: Firefly Medical Ltd www.fireflymedical.co.uk PRIZE SPONSOR: Boots Centre for Innovation www.bootsinnovation.com

The Innovation Award was won by Firefly Medical Ltd, for their Single Use Vaginal Speculum called Puraspec. The winning entry, the Puraspec Speculum, is the leading product in the market for over 6 million procedures in the UK every year. The product has been designed to be considerably stronger than the competition, with a break safe feature designed into the

Outstanding Growth Award WINNER: DTR Medical Ltd www.dtrmedical.com PRIZE SPONSOR: Abel and Imray Patent Attorneys www.patentable.co.uk

REVIEW-Arab Health 10

11/1/10

10:55

Page 11

handle to prevent breakages within the patient. It is quicker to use and is ergonomically designed. Firefly Medical Ltd was established to develop medical products for the NHS and primary care customers, offering selective sales of leading equipment, consumables and pharmaceuticals. They have an experienced external sales team with strengths in occupational health, primary care and sexual health. They are IS013485:2003 accredited and have a pharmaceutical wholesale dealer’s license. Firefly also won the Start Up Award, presented to a newly established company in the healthcare sector that show a promising future. Firefly Medical Ltd demonstrated promising success within their first 18 months. They’ve sold 3rd party products through the development of an excellent ‘Web shop’ integrated into Sage accounts. They have also launched a catalogue and carried out e-mail marketing. They’ve recruited 2 experienced external sales staff and their buyer has direct contacts and experience in sourcing from all the leading medical supplies manufacturers. They quickly gained their pharmaceutical license and ISO 13485:2003 accreditation. Firefly have launched their own niche product

(Puraspec). Required by every G.P in the U.K, this product has been immediately accepted onto the English NHS Framework and is best in class, in a market for 1.8 Million speculums each year. The Export Achievement Award was won by The Magstim Company Ltd, for increasing their total exports by over 35.7%. Magstim identified new markets in USA, China, Middle East and Japan and have established and maintained exclusive distribution agreements with companies in these territories. The combined results from Brazil, China and Middle East gave Magstim sales in the first three quarters of calendar 2009, which was more than double that of the preceding year. Magstim provides the means for neuroscientists to work with the human brain in awake subjects by manufacturing and supplying state-ofthe-art clinical and research instruments. Magstim products cover the fields of neurology, neurophysiology, psychiatry, cognitive neuroscience as well as ENT, orthopaedic and neuro-surgery. Magstim maintains a strong commitment to R&D and product improvement. Collaborating with researchers in British and European

Export Achievement Award WINNER: The Magstim Company Ltd www.magstim.com PRIZE SPONSOR: UDL www.udl.co.uk

major centres of expertise (as well as those in North America and Japan) ensures that Magstim remains informed about clinical and medical advances, enabling the company to develop products at the forefront of technology. Products are sold directly to hospitals and clinics in the UK and Ireland, with other principal markets in Germany, France, Benelux, Japan, the Far East and the USA. Magstim enjoys a close and effective relationship with its specialist distributors and provides significant training and after sales services. DTR Medical won the Outstanding Growth Award, for consistent, sustainable and profitable growth in the sector. Their entry demonstrated consecutive growth in sales over the past 14 quarters, resulting in Q3 09 now matching total annual performance for 2006. They have achieved this growth due to their development strategy: to innovate for the needs of single-use disposables versus the traditional requirements for autoclaving. The result is the creation of four distinct catalogues with the product lines expanding from 66 to 440 in four years. Medical sales in 2008 showed 66% growth, and in 2009-10 growth

Partnership with NHS/Academia Award WINNER: Invacare UK www.invacare.co.uk PRIZE SPONSOR: Catalyst Venture Partners www.catvp.com

REVIEW-Arab Health 10

M E D I W A L E S

11/1/10

10:55

R E V I E W

Page 12

S P R I N G

2 0 1 0

A W A R D S

12 remains at over 50% p.a. DTR Medical provides medical professionals with high quality singleuse sterile disposables that deliver clinical value combined with exceptional levels of service. The company has operated for four years, during which time it won over 400 UK and International customers and has expanded the product range dramatically to meet new market demands. The range includes many new sterile single-use surgical instruments for specialists including ENT, neurosurgery, vascular and general surgery, and gynaecological procedures. In addition the company supplies a range of products for sterile services including sterile pre-cut silicone tubing. The Partnership with the NHS/Academia Award went to Invacare Ltd for their Homefill oxygen system. Invacare have worked with Dolby Medical the Scottish oxygen contractor and NHS Oxygen Management to develop a patient trial for the Invacare Homefill oxygen filling system, which allows the patient to fill ambulatory oxygen cylinders and be supplied with oxygen via a concentrator at the same time. The risk assessment, trial protocol, and clinical / patient product training have been developed in partnership. Invacare supply the UK healthcare market and the NHS with a range of products which include beds,

mattresses, cushions, walking aids, bathing and hygiene, moving and handling respiratory equipment. The Judges’ Award went to Norgine Ltd, for their outstanding growth. On a constant currency basis, Norgine’s product sales increased by just over 10%. 2008 was therefore Norgine’s 22nd consecutive year of double digit growth.Founded in 1906, Norgine is a specialty pharmaceutical company with an extensive panEuropean presence. They focus on pharmaceutical products that address significant unmet clinical need in areas such as gastroenterology, hepatology and pain management. Throughout their long history, they have sought to develop and market high quality, innovative products for the benefit of both patients and physicians. They are committed to developing products not only to treat life-threatening conditions but, importantly, to improve the quality of life for patients with a range of acute and chronic illnesses. They have a long standing tradition of building relationships, based on the highest standards, with patients, physicians, employees, partners and other key stakeholders.

Development base of the company. They are committed to developing products not only to treat lifethreatening conditions but, importantly, to improve the quality of life for patients with a range of acute and chronic illnesses. The NHS Innovation within the NHS Award went to Marilyn Williams Radiology Department of the Aneurin Bevan University Health Board. Marilyn Williams won the Innovation within the NHS Award for a new service that’s introduced patientfocused booking for all Radiology patients across Gwent. This service has provided the department with one waiting list, reduced waiting times and one process for all appointments. Prior to the start of the project in 2008, radiology appointments were arranged by different groups of staff in local departments with varying waiting times and different processes. The new service was to introduce Patient Focused Booking for all Radiology Patients across Gwent, one waiting list, reduce wait times and have one process for all appointments and set up the Radiology Booking Service.

In the last fifteen years, they have focused on expanding their panEuropean infrastructure, and have moved to strengthen the Research &

Judge's Award WINNER: Norgine Ltd www.norgine.com

Innovation within the NHS Award WINNER: Marilyn Williams, Radiology Department for Aneurin Bevan Health Board www.wales.nhs.uk/sitesplus/866 PRIZE SPONSOR: Chapman Molony Patent & Trade Mark Attorneys www.chapmanmolony.com

REVIEW-Arab Health 10

11/1/10

10:55

Page 13

13 The NHS Partnership with Industry/Academia Award went to Dr Jane Lewis ( Podiatry department of the Cardiff and Vale University Healthboard). The Podiatry Department - at Cardiff and Vale University Health Board collaborated with Huntleigh Healthcare in Cardiff in the production of the Dopplex Ability, a device for identifying peripheral arterial disease (PAD) – a prevalent but often missdiagnosed disease. This device addresses three needs: to improve the identification of PAD, the quality of referrals, and improve cardiovascular morbidity and mortality.

shorter appointment times and increases patient through put. It also allows for earlier diagnosis and intervention for lifestyle changes, which can lead to treatment of risk factors resulting in fewer inappropriate referrals for costly vascular consultations and duplex scanning. Another knock-on effect is the reduction in the number of hospital admissions and amputations with a derived reduction in the pressure on surgery and intensive care capacities at vascular surgery departments; fewer premature deaths would be expected.

The device works via the simultaneous inflation of blood pressure cuffs, which obviates the need for the patient to be rested and considerably reduces the assessment time. Consultations regarding clinical need, patient need and equipment design between the Podiatry department and Huntleigh Healthcare have been ongoing throughout the development and testing of the product. Key design inputs have been fed into the project to determine ease of use, acceptability and reproducibility in a clinical environment.

The NHS Judges’ Award went to Stuart Jones, from Cwm Seren Hywel Dda Health Board The Judges Award is presented to the entry which the judges feel best demonstrates the spirit of the innovation Awards. Cwm Seren is an Acute Psychiatric Unit that provides inpatient mental health services for West Carmarthenshire and South Ceredigion. Lack of understanding of mental health services by the police led to the following initiative: Initial Police Learning & Development Programme (IPLDP) of Dyfed Powys Police (DPP)– Mental Health Placement in partnership with Hywel Dda Health Board (HDHB). Stuart is based at Cwm Seren, an

The test takes approximately 5 minutes - compared to the current method that requires 15mins rest plus 10-25 mins testing time.Dopplex Ability gives greater patient comfort,

NHS Partnership with Academia and Industry Award WINNER: Dr Jane Lewis, Department of Podiatry, Cardiff and Vale University Health Board www.wales.nhs.uk/sitesplus/864 PRIZE SPONSOR: Wynne-Jones, Laine & James LLP www.wynne-jones.com

Acute Psychiatric Unit providing inpatient mental health services for West Carmarthenshire and South Ceredigion. He set up the prize winning Initial Police Learning & Development Programme (IPLDP) to address the local police’s lack of understanding of mental health issues and services. Through the scheme, student police officers within Dyfed Powys Police attended a six day placement with the mental health services, learning about Mental Health First Aid and engaging with staff, patients, patient user groups and professionals in the unit. Learning firsthand the patients’ own experiences, the police have been applauded for a more positive attitude towards them. Student officers have a pre-arranged time table of 2 days learning about Mental Health First Aid along with a 4 day placement in the mental health unit covered by their Base Command Unit. This enables the officers to engage with staff, patients, patient user groups and professionals in mental health care. It involves them in all aspects of mental health provision and allows them first hand access to patients’ experiences and services provided by the Trust.

NHS Judge's Award WINNER: Stuart Jones, Cwm Seren - Hywel Dda Health Board www.wales.nhs.uk/sitesplus/862

REVIEW-Arab Health 10

11/1/10

10:55

Page 14

Inspired coatings from a global leader

e at

h a b le F il m

Fri

Our inspireâ&#x201E;˘ portfolio is based on a proven record in the design and manufacture of high performance materials for wound dressings, ostomy products, incise films and medical conductive films for use in EKG, EEG and TENS.

e n dly A d h e

s iv

DATA and the BILL OF RIGHTS for Patients If DATA from Star Trek were a patient in the NHS he would have RIGHTS, so why not other data? RIGHT decisions require The RIGHT data, at the RIGHT time, from the RIGHT place, using the RIGHT collection method.

ndu

lm c t i ve F i

The National AIDC Centre for Wales (Automatic Identification and Data Capture) has been set up as a Knowledge Transfer Centre under the Academic Expertise for Business (A4B) scheme of WAG to help companies achieve just those aims. The scheme is Pan-Wales based at the University of Glamorgan with representation in Swansea, Aberystwyth, and Wrexham to provide help to organisations wishing to adopt ANY of the AIDC technologies, which include:linear and 2D bar codes, active and passive RFID, and biometrics. AIDC is an enabling technology with potential application areas in every aspect of business. And the BILL, if you are a Welsh based organisation is nothing for up to 3 days consultation, and feasibility study. Contact Hywel Williams on 01443-654542 or hwillia5@glam.ac.uk www.aidcwales.org or www.aidc.org

n for m a ble

cte

r i al B a r r ie

When you need a partner who understands your requirements, explores the options and provides innovative solutions for demanding applications, look no further than Exopack Advanced Coatings. Contact us on

+44 (0)1978 660 241 geninf@exopack.com

Exopack Advanced Coatings, Wrexham Industrial Estate, Wrexham LL13 9UF

www.exopackadvancedcoatings.com

REVIEW-Arab Health 10

11/1/10

A R A B

10:55

Page 15

H E A L T H

Arab Health Company Directory

Showcases Ultrasound Technologies DTR Medical Boots Centre for Innovation

S E C T I O N

2 0 1 0

REVIEW-Arab Health 10

11/1/10

10:55

Page 16

20 years in the field

Visit www.magstim.com for more information. T: +44 (0)1994 240798 E: sales@magstim.com

REVIEW-Arab Health 10

11/1/10

10:55

Page 17

A R A B H E A LT H - W A L E S PA V I L I O N D I R E C T O R Y

Go East The Middle East’s leading healthcare exhibition and congress is growing. Arab Health touches upon all aspects of the healthcare industry in the Middle East.

makers in the Arab world. With rapid year-

Tens of thousands of medical professionals,

The Welsh Pavilion

government officials, wholesalers, dealers and distributors converge on the Dubai International Exhibition Centre every year for the region’s main event for the healthcare

on-year growth, Arab Health now has over 2,500 exhibitors from 65 countries including over 100 stands from UK companies. The show will attract over 50,000 visitors over the four-day event.

Several companies will be exhibiting from Wales, including: Chromogenex

industry. With the addition of 20,000 sqm at the Dubai International Exhibition Centre, Arab Health has, for the first time in several years, the opportunity to grow and become an even bigger event.

DTR Medical Roma Medical Aids Ltd

International Business Wales Welsh Assembly Government Department for the Economy and Transport Trafalgar House 5 Fitzalan Place Cardiff, Wales CF24 0ED Tel: +44(0)2920 828 786 Web: www.ibwales.com Geraldine Newbery – Mission Leader Geraldine is involved in international trade development activity in the Middle East and Africa. This primarily involves managing and leading key overseas trade fairs and missions to the region. Email: geraldine.newbery@wales.gsi.gov.uk Lee Jennings - Vice President (Middle East) The International Business Wales office in Dubai is responsible for trade and investment development throughout the Middle East and North Africa. The office has been in existence since March 2004 and is managed by Lee Jennings, who has over 25 years experience of trade and business development covering China, South East Asia, Southern Asia and more recently, 8 years in the Middle East. Lee manages a network of business experts throughout the Arabian Gulf and is able to assist Welsh companies with research, information and a wide range of contacts and advice. Mobile: +971 50 559 3668 Email: lee.jennings@ibwales.com

Ultrasound Technologies Ltd

International Business Wales has arranged for several Welsh firms to attend the Arab Health Mission, allowing them the opportunity to network with bioscience and medical professionals from all over the world. With thousands of delegates and hundreds of exhibitors, the Arab Health Mission will

International Business Wales (IBW) is the organiser of the Welsh Pavilion at Arab Health. IBW is the international trade and investment arm of the Welsh Assembly Government. They act as a driving force in

promote Welsh Bioscience in an international

establishing alliances between companies in

arena, and publicise the positive work going

Wales and their counterparts overseas. IBW

on in Wales.

also actively encourages inward investment

Arab Health 25 – 28 January 2010 – Dubai International Convention and Exhibition Centre, UAE. The Welsh Pavillion: Hall 7 B53 The Arab Health exhibition is the premier healthcare event for the Middle East. This event plays host to healthcare manufacturers,

MediWales is supported by the Welsh Assembly Government

from overseas companies looking to Europe and the UK as a preferred international business location.

M E M B E R

The Arab Health section of this Review has been produced in collaboration with IBW: it includes a directory of companies visiting and

wholesalers and distributors. It provides these

exhibiting at the exhibition, with more detailed

professionals with an opportunity to meet

case studies on a selection of attending

with some of the most important decision

companies.

7 Schooner Way, Atlantic Wharf, Cardiff CF10 4DZ T/F: +44 29 2047 3456 Email: debbie.laubach@mediwales.com coralie.palmer@mediwales.com gwyn.tudor@mediwales.com jo.daniel@mediwales.com Web: www.mediwales.com Chairman: Mr Greg Baily, Huntleigh

REVIEW-Arab Health 10

M E D I W A L E S

11/1/10

11:02

R E V I E W

Page 18

S P R I N G

2 0 1 0

S H O W C A S E

Arab Health 25 – 28 January 2010 - Dubai International Convention and Exhibition Centre, UAE

The Welsh Pavilion: Hall 7 Stand B53 International Business Wales

Geraldine Newbery

Mission Leader, Middle East and Africa Web site: www.walestrade.com Description: HALL 7, Stand B53 Lee Jennings Tel: +971 50 559 3668 Email: lee.jennings@ibwales.com

IBW Trafalgar House Fitzalan Place Cardiff Wales UK CF24 0ED Tel: +44(0)2920 828 786 Fax: +44 (0)2920 442 696 Email: geraldine.newbery@wales.gsi.gov.uk Web: www.ibwales.com

International Business Wales is the Welsh Assembly Government’s international trade and investment arm. It forms part of the Department for the Economy and Transport and acts as the driving force in establishing alliances between companies in Wales and their counterparts overseas, whilst actively seeking out inward investment opportunities for client companies looking to Europe and the UK as a preferred international business location. Geraldine is involved in international trade development activity in the Middle East and Africa. This primarily involves managing and leading key overseas trade fairs and missions to the region. Geraldine and Lee will be on hand to assist the attending companies during the duration of the exhibition.

53 Ogwen Drive Lakeside Cardiff CF 23 6LJ Tel:- +44 (0)29200766676 Fax :- :+44 (0)29200766676 Email: mkurukchi@yahoo.co.uk

Asia Scientific Supply Company is the corner stone for the export of British products to Iraq where our partners Asia Scientific Bureau and Al-Hirse Company are dealing with the private and government sectors in the fields of medical, agriculture, scientific and oil.

Units 1&2 Heol Rhosyn Dafen Park Llanelli SA14 8QG Tel: 01554 755444 Fax: 01554 755444 kwilliams@chromogenex.com www.chromogenex.com

Chromogenex design, manufacture and service lasers and intense light systems for the health and beauty market. Key products are: ilipo – a body shaping fat reducing device without the need for pain, needles or downtime. Chromolite/Phaser – intense pulse light for hair removal, skin rejuvenation and pigmentation. Regenlite – a pulse dye laser for vascular, acne and skin pigmentation. The company also sells consumables, service contracts and other ancillary goods. Chromogenex has established direct sales operations in the UK, French and Canadian markets and makes further export sales via a comprehensive network of distributors.

Asia Scientific Supply Mission delegates Muthaffar Ameen Behnam Kurukchi Pat Trigg

Chromogenex

Peter McGuiness Kevin Williams

REVIEW-Arab Health 10

11/1/10

11:02

Page 19

A R A B H E A LT H - W A L E S PA V I L I O N D I R E C T O R Y

19 5

DTR

Andrew Davidson Managing Director

17 Clarion Court Enterprise Park Swansea SA6 8RF Tel: 01792 797910 Fax: 01792 797955 Email: adavidson@dtrmedical.com Web: www.dtrmedical.com

DTR Medical aim to provide medical professionals with high quality single-use sterile disposables that deliver patient and clinical value combined with exceptional levels of service. The company has operated in this market for over three years, during which time it won some 350 new customers. The range includes sterile single-use disposable surgical instruments and related theatre and clinic products, for specialities including ENT, neurosurgery, vascular and general surgery, and gynaecological procedures. In addition, the company supplies a range of products for sterile services.

Roma Medical Aids Ltd, York Road, Bridgend Industrial Estate, Bridgend, CF31 3TB. Tel. 01656 674488 Fax. 01656 674499 Web. www.romamedical.co.uk

Roma Medical Aids Ltd is recognised as one of the leading UK manufacturers and suppliers of mobility, medical and rehabilitation equipment. The product range consists of manual wheelchairs, power wheelchairs, electric scooters, walking aids, rollators, commodes, bathing aids, toileting aids, shower equipment and homecare equipment. At Arab Health, the latest range of Anti-Microbial Sanichairs will be displayed, which have been recently introduced with great success into the UK hospital market. Incorporating many patented features and manufactured in the UK from the highest quality materials, the RomaChair has been developed with close co-operation with hospital staff, clinicians and Infection Control managers. Roma Medicals objectives for Arab Health are to build on existing contacts and establish new contacts in the Gulf region. We look forward to meeting with you at our stand.

Ultrasound Technologies Ltd Lodge Way Portskewett Caldicot NP26 5PS UK Tel: +44 (0)1291 425425 Fax: +44 (0)1291 427093 email:ultratec@doppler.co.uk Web: www.doppler.co.uk

Ultrasound Technologies has a history of over 25 years in fetal and vascular doppler systems. We offer over 12 doppler models, from simple fetal audio units to those including fetal heart rate display. Vascular products are available with a choice of fine pencil probe or standard vascular pocket units for routine vascular investigation and ABPI testing. Fetal monitoring covers all antepartum and intrapartum applications with the fetatrack 310 and fetatrack 360, offering easy-to-use systems from Ultrasound monitoring to continuous fetal pulse oximetry. All the units have been designed by Ultrasound Technologies and are manufactured in the companyâ&#x20AC;&#x2122;s ISO9000:2000/ ISO13485:2003 certified factory in Caldicot, South Wales. Ultrasound Technologiesâ&#x20AC;&#x2122; products are sold in over 90 countries world-wide and supported by a team of distributors in each country.

Roma Medical

Stand contacts Simon Dalton Managing Director Email: sdalton@romamedical.co.uk John Dalton Consultant Email: jdalton@romamedical.co.uk

Ultrasound

Nick See Ann See

REVIEW-Arab Health 10

M E D I W A L E S

11/1/10

11:02

R E V I E W

Page 20

S P R I N G

S H O W C A S E

2 0 1 0

Ultrasound Technologies Ltd Ultrasound Technologies designs and manufactures complex medical electronic products from their design and manufacturing centre in Caldicot, South Wales. This includes a range of fetal and vascular Dopplers as well as fetal monitors which they export internationally through a large network of distributors.

New Designs and products: Using “soft” design techniques Ultrasound Technologies are introducing a series of units that are aesthetically pleasing and friendly, reducing fear and stress to the patient. The first to be shown at Arab Health 2010 is their newest product, the Fetatrack DD250 which offers continuous fetal and vascular Doppler in the small clinic, hospital or doctors office. Weighing under 2Kg the Fetatrack DD250 is a truly portable unit. It will operate from a mains supply or for over 30 hours from its built-in rechargable batteries. The Fetatrack DD250 has all the necessary facilities for accurate antenatal fetal assessment in one cost effective and compact unit. With its full digital multipoint autocorrelation the fetal heart detection it provides is accurate and reliable with the display of fetal heart rate on a large easy to read LCD display. Simple to operate the DD250 is designed with one control that turns the unit on/off and adjusts the volume.

Fetal heart records can be kept by using the FetaTrace software that is available as a monitoring package with the option of a wide angle monitoring transducer.

Ultrasound Technologies, are very happy to be a part of this fantastic product. For more information please visit www.doppler.co.uk

All Fetatrack products come with a standard 3 year warranty lowering the cost of ownership. With over 25 years of supplying fetal heart detectors and monitors you can be assured that any problem your Fetatrack unit will encounter over its lifetime will be fixed quickly and reliably.

Evolutionary Design: Ultrasound Technologies in a design collaboration with their partner Freeplay Energy of Cape Town recently won the ‘Index Award : Design To Improve Life’ for the first ever self powered Doppler to be used in developing countries around the world, where power is not available. At the award ceremony in Copenhagen Unicef stated that they are a strong believer that this little Doppler will help to save millions of mothers and babies across the world and we,

Ultrasound Technologies Ltd Lodge Way Portskewett Caldicot NP26 5PS United Kingdom T: +44 (0) 1291 425425 F: +44 (0) 1291 427093 E: ultratec@doppler.co.uk

REVIEW-Arab Health 10

11/1/10

11:03

Page 21

A R A B H E A LT H - W A L E S PA V I L I O N D I R E C T O R Y

DTR Medical DTR Medical – the rapidly growing specialist in sterile single-use surgical instruments – is seeing a significant rise in enquiries from many parts of Europe, the Middle East, and beyond, underlying the growing need for high quality disposable equipment. DTR Medical believes there are several factors influencing the increase in sales for sterile single use equipment. Firstly, single-use disposables reduce the risk of crosscontamination. Complications like surgical site infections and extended hospital stays are minimised, which lowers costs and reduces potential litigation. Secondly, disposables rule out reprocessing – the need to clean reusable instruments. Reprocessing is a difficult and timely process, often leading to delayed patient throughput and raised costs from high manual handling rates. Another positive with single-use disposables is that they don’t need constant validation and repair, which is expensive, and can disrupt theatre procedures if reworking is delayed. Lastly, there is the issue of replacement capital with reusable units, as multiple sets are required to cope with high patient numbers. This is even more expensive when reprocessing is done away from the clinical location, which increases the cost over the funding estimates. These cumulative cost-saving and patient benefits are being noticed far and wide. During a recent international ENT symposium in London – the 27th Politzer Society – leading surgeons

from across Europe expressed interest in using DTR Medical’s single-use instruments in their own clinical practise. Some delegates were so

instruments - the Frazier Suction Handle Range – in order to allow for greater flexibility and efficiency. The range now includes two and four tip

committed to these potential benefits, that they placed orders during the meeting.

fenestrations, and is used across most surgical specialities. This modification to the manufacturing process has enabled the potential for more lines of products. A similar approach has been used to produce a range of sterile single-use Tibbs Arterial Cannula, which are used in many vascular procedures.

Single-use surgical instruments are not designed to replace all re-usable items, as they are most effective when used selectively to resolve a combination of the above factors. Managers of sterilisation services welcome the disposable items as they help them to combat the issues faced by utilising re-usable instruments. For instance, validating the sterility of long lengths of tubing is often problematic: DTR Medical eradicates this problem by supplying its range of pre-cut lengths of sterile silicone tubing, which are now being sold as far afield as New Zealand. To help hospital efficiency, single-use disposable instruments must be of a consistently high quality, and be readily available at all times. DTR Medical takes particular care to ensure that every instrument meets specification. To keep up with the demands of their clients, the company is continually improving and re-evaluating its systems. They recently changed their method of manufacturing a series of medical

Growing international demand means DTR Medical is looking forward to the future, and is creating new partnerships with Welsh Universities to deliver major new lines, including developments in gynaecological surgery.

DTR Medical Swansea SA6 8RF T: +44 (0) 1792 797910 F: +44 (0) 1792 797955 E: adavidson@dtrmedical.com Web: www.dtrmedical

REVIEW-Arab Health 10

M E D I W A L E S

11/1/10

11:03

R E V I E W

Page 22

S P R I N G

S H O W C A S E

2 0 1 0

Boots Centre for Innovation Maintain your Equilibrium: a calming solution for ‘stressed’ consumers Boots Equilibrium® is a food supplement which aims to help people manage the pressures of modern life. It contains a unique patented ingredient, Lactium®, which can provide calming support to help with the stresses and strains of everyday life. Lactium is a bio-protein isolated from milk which has been studied extensively for over ten years and has relaxing properties that reduce and regulate stress-related troubles naturally.

appropriate for new health and wellness products. The BCI investigated the claims and science behind all the opportunities and quickly established a technical interest in Lactium and its calming properties. It was a food-grade, patented product that represented a breakthrough in the field of nutrition.

Meeting a consumer need

The BCI had identified sleep, stress and energy as a sector with a key unmet healthcare need and was looking for solutions to address this market in response to customer demand. The organisation spoke to experts on the mechanics of sleep and the links to everyday stresses caused by modern lives, and also commissioned research to identify the products consumers are happy to use. This revealed a reluctance to use traditional sleeping pills and a preference for supplements and drinks.

Lactium is now available in the UK for the first time in Boots Equilibrium. It is offered in two different formats: a convenient once-a-day capsule in 7 or 14 day packs and a comforting hot chocolate drink.

Initial developments

Lactium was first developed by research scientists in the 1990s. It has shown proven efficacy on humans in six clinical studies using validated biological indicators and randomised, double-blind and placebo controlled procedures. The Boots Centre for Innovation (BCI) team was introduced to Lactium by a Cheshire company, Fayrefield FoodTec, which specialises in providing innovative food ingredients. Fayrefield FoodTec presented the BCI with a number of novel ingredient opportunities that it believed could be

Consumers want tailored solutions for their individual needs which will help them relax and unwind before bed and have an uninterrupted night’s sleep. This includes both quick fixes for temporary problems, such as to help them sleep when they have a cold, and solutions which deal with the root causes for long term sufferers. Lactium appeared to have considerable potential in this market, provided that suitable product formulations could be developed.

BCI’s role in the development

BCI began by establishing Lactium’s scientific credibility. They then worked with colleagues in the Boots healthcare team to assess the commercial opportunity for Boots. Having concluded that a potential market existed, BCI introduced Fayrefield FoodTec to the Alliance Boots product development team and the businesses worked together to

develop product formulations using Lactium. Twenty months later, the two product formats were launched to consumers. Gail Eastaugh, the BCI’s business development manager, comments: “This is a great example of how the BCI can take external innovation which is supported by thorough clinical evidence and, using Boots’ expertise in formulation, marketing and packaging, develop a winning product for our customers.” Steve Timms, sales and business development director from Fayrefield FoodTec, said: “Developing the Equilibrium product and bringing it to market has been much easier than I had expected, with the team at BCI supporting me every step of the way. They have a great deal of expertise, and without their support and the open approach from BCI the whole process would have been a lot tougher.” The products were launched in September 2009, and are selling well. Boots was so confident about Equilibrium with Lactium that the initial launch was supported with a ‘feel the difference or your money back’ guarantee on seven-day packs of Equilibrium, allowing customers to experience the benefits for themselves. Boots healthcare expert Gavin Stainton concludes: “Boots Equilibrium with Lactium offers anyone who feels under everyday pressure an aid to deal with it. The expertise behind this product makes it one of the most exciting launches this decade.” Boots Centre for Innovation Institute of Life Science University of Swansea Swansea SA2 8PP Wales UK Tel: +44 (0)1792 513 722 Email: info@bootsinnovation.co.uk Web: www.bootsinnovation.com

REVIEW-Arab Health 10

11/1/10

11:03

Page 23

REVIEW-Arab Health 10

11/1/10

11:42

Page 24